Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)
NCT ID: NCT06181994
Last Updated: 2024-12-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
5000 participants
OBSERVATIONAL
2023-12-05
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Endovascular embolization of middle meningeal artery using any embolization material:
PVA particles; Onyx, nBCA glue; dimethyl sulfoxide, microcoils, PVA with microcoils
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Geisinger Clinic
OTHER
Heidelberg University
OTHER
Henri Mondor University Hospital
OTHER
Ospedale Policlinico San Martino
OTHER
Ospedale San Raffaele
OTHER
Lehigh Valley Hospital
OTHER
Mayo Clinic
OTHER
Medical University of South Carolina
OTHER
New York University
OTHER
Oregon Health and Science University
OTHER
Sisters of Mercy University Hospital
OTHER
Unity Health Toronto
OTHER
Sutter Health
OTHER
University of Iowa
OTHER
Thomas Jefferson University
OTHER
University Health Network, Toronto
OTHER
University Hospital, Bordeaux
OTHER
University of Alabama at Birmingham
OTHER
University of South Florida
OTHER
University of Washington
OTHER
Cornell University
OTHER
Westchester Medical Center
OTHER
Montefiore Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Altschul, MD
Role: PRINCIPAL_INVESTIGATOR
Montefiore Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Montefiore Medical Center
The Bronx, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Muhammed Amir Essibayi, MD
Role: primary
David Altschul, MD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023-15327
Identifier Type: -
Identifier Source: org_study_id